Effects of 3H-1,2-dithiole-3-thione, 1,4-phenylenebis(methylene) selenocyanate, and selenium-enriched yeast individually and in combination on benzo[a]pyrene-induced mutagenesis in oral tissue and esophagus in lacZ mice

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 559, Issue 1-2, 2004, Pages 199-210

  Guttenplan, Joseph B ^a   Spratt, Thomas E ^b   Khmelnitsky, Michael ^a   Kosinska, Wieslawa ^a   Desai, Dhimant ^b   El Bayoumy, Karam ^b  

^a NEW YORK UNIVERSITY   (United States)

^b AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

1,4 phenylenebis(methylene) selenocyanate; 3H 1,2 dithiole 3 thione; Benzo a pyrene; Chemoprevention; D3T; Dithiolethione; lacZ; MF; Mutagenesis; Mutant fraction; p XSC; pfu; Plaque forming units; Selenium; Selenium enriched yeast; SeY

Indexed keywords

1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; 3H 1,2 DITHIOLE 3 THIONE; ANTIMUTAGENIC AGENT; BENZO[A]PYRENE; BETA GALACTOSIDASE; SELENIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG EFFECT; DRUG EFFICACY; ESOPHAGUS CANCER; FEEDING; LOW DRUG DOSE; MALE; MOUSE; MOUTH; MOUTH CANCER; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TONGUE; YEAST;

ANIMALS; ANTIMUTAGENIC AGENTS; BENZO(A)PYRENE; DNA; DRUG COMBINATIONS; ESOPHAGUS; MALE; MICE; MUTAGENESIS; MUTAGENICITY TESTS; ORGANOSELENIUM COMPOUNDS; SELENIUM; THIONES; THIOPHENES; TONGUE; YEASTS;

GALE;

EID: 1842579595     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.02.002     Document Type: Article

References (47)

1. Johnson N. Tobacco use and oral cancer: a global perspective. J. Dent. Educ. 65:2001;328-339.
2. Jemal A., Thomas A., Murray T., Thun M. Cancer statistics, 2002, CA. Cancer J. Clin. 52:2002;23-47.
3. Parkin D.M., Pisani P., Ferlay J. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int. J. Cancer. 54:1993;594-606.
4. Blot W.J., McLaughlin J.K., Winn D.M., Austin D.F., Greenberg R.S., Preston-Martin S., Bernstein L., Schoenberg J.B., Stemhagen A., Fraumeni J.F. Jr. Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res. 48:1988;3282-3287.
5. Smith C.J. Oral cancer and precancer: background, epidemiology and aetiology. Br. Dent. J. 167:1989;377-383.
6. Hecht S.S. Tobacco smoke carcinogens and lung cancer. J. Natl. Cancer Inst. 91:1999;1194-1210.
7. Hoffmann D., Hoffmann I., El-Bayoumy K. The less harmful cigarette: a controversial issue. a tribute to Ernst L. Wynder. Chem. Res. Toxicol. 14:2001;767-790.
8. Culp S.J., Gaylor D.W., Sheldon W.G., Goldstein L.S., Beland F.A. A comparison of the tumors induced by coal tar and benzo[a]pyrene in a 2-year bioassay. Carcinogenesis. 19:1998;117-124.
9. von Pressentin M.M., Kosinska W., Guttenplan J.B. Mutagenesis induced by oral carcinogens in lacZ mouse (MutaMouse) tongue and other oral tissues. Carcinogenesis. 20:1999;2167-2170.
10. Rojas M., Alexandrov K., Cascorbi I., Brockmoller J., Likhachev A., Pozharisski K., Bouvier G., Auburtin G., Mayer L., Kopp-Schneider A., Roots I., Bartsch H. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/Msp-GSTM1*0/*0 genotypes. Pharmacogenetics. 8:1998;109-118.
11. Clark L.C., Combs J.F.J., Turbull B.W., Slate E.H., Chalker D.K., Chow J., Davis L.S., Glover R.A., Graham G.F., Gross E.G., Krongrad A., Lesher H.L.J., Park H.K., Sanders B.B.J., Smith C.L., Taylor J.R. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial, Nutritional Prevention of Cancer Study Group. JAMA. 276:1996;1957-1963.
12. Ganther H.E. Selenium metabolism, selenoproteins and mechanisms of cancer prevention: complexities with thioredoxin reductase. Carcinogenesis. 20:1999;1657-1666.
13. Rayman M.P. The importance of selenium to human health. Lancet. 356:2000;233-241.
14. El-Bayoumy K. The protective role of selenium on genetic damage and on cancer. Mut. Res. 475:2001;123-139.
15. Ip C. Lessons from basic research in selenium and cancer prevention. J. Nutr. 128:1998;1845-1854.
16. Tanaka T., Makita H., Kawabata K., Mori H., El-Bayoumy K. 1,4-Phenylenebis(methylene)selenocyanate exerts exceptional chemopreventive activity in rat tongue carcinogenesis. Cancer Res. 57:1997;3644-3648.
17. von Pressentin M.M., El-Bayoumy K., Guttenplan J.B. Mutagenic activity of 4-nitroquinoline-N-oxide in upper aerodigestive tissue in lacZ mice (MutaMouse) and the effects of 1,4-phenylenebis(methylene)selenocyanate. Mut. Res. 466:2000;71-78.
18. Guttenplan J.B., Kosinska W., von Pressentin M.M., Rosa J., El-Bayoumy K. Effects of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) and vitamin E on 4-nitroquinoline-N-oxide (4-NQO)-induced mutagenesis in lacZ mouse upper aerodigestive tissue. Mut. Res. 518:2002;85-93.
19. Ansher S.S., Dolan P., Bueding E. Biochemical effects of dithiolthiones. Food Chem. Toxicol. 24:1986;405-415.
20. Steinmetz K.A., Potter J.D. Vegetables, fruit, and cancer prevention: a review. J. Am. Diet. Assoc. 96:1996;1027-1039.
21. Van Duyn M.A., Pivonka E. Overview of the health benefits of fruit and vegetable consumption for the dietetics professional: selected literature. J. Am. Diet. Assoc. 100:2000;1511-1521.
22. Kensler T., Styczynski P., Groopman J., Helzlsouer K., Curphey T., Maxuitenko Y., Roebuck B.D. Mechanisms of chemoprotection by oltipraz. J. Cell Biochem. Suppl. 16I:1992;167-172.
23. Kensler T.W. Chemoprevention by inducers of carcinogen detoxication enzymes. Environ. Health Perspect. 105(Suppl. 4):1997;965-970.
24. B.D. Roebuck, T.J. Curphey, Y. Li, K.J. Baumgartner, S. Bodreddigari, J. Yan, S.J. Gange, T.W. Kensler, T.R. Sutter, Evaluation of the cancer chemopreventive potency of dithiolethione analogs of oltipraz, Carcinogenesis (2003) 1919-1928.
25. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
26. Hollstein M.C., Sidransky D., Vogelstein B., Harris C.C. p53 mutations in human cancer. Science. 253:1991;49-53.
27. Myhr B.C. Validation studies with MutaMouse: a transgenic mouse model for detecting mutations in vivo. Environ. Mol. Mutagen. 18:1991;308-315.
28. Hoorn A.J., Custer L.L., Myhr B.C., Brusick D., Gossen J., Vijg J. Detection of chemical mutagens using MutaMouse: a transgenic mouse model. Mutagenesis. 8:1993;7-10.
29. Thybaud V., Dean S., Nohmi T., de Boer J., Douglas G.R., Glickman B.W., Gorelick N.J., Heddle J.A., Heflich R.H., Lambert I., Martus H.J., Mirsalis J.C., Suzuki T., Yajima N. In vivo transgenic mutation assays. Mut. Res. 540:2003;141-151.
30. Morse M.A., Stoner G. Cancer chemoprevention: principles and prospects. Carcinogenesis. 14:1993;1737-1746.
31. Wattenberg L.W. An overview of chemoprevention: current status and future prospects. Proc. Soc. Exp. Biol. Med. 216:1997;133-141.
32. Stoner G.D., Morse M.A., Kelloff G.J. Perspectives in cancer chemoprevention. Environ. Health Perspect. 105(Suppl. 4):1997;945-954.
33. Cerutti P.A., Trump B.F. Inflammation and oxidative stress in carcinogenesis. Cancer Cells. 3:1991;1-7.
34. Cerutti P., Shah G., Peskin A., Amstad P. Oxidant carcinogenesis and antioxidant defense. Ann. N.Y. Acad. Sci. 663:1992;158-166.
35. McCormick D.L., Wilson A.M. Combination chemoprevention of rat mammary carcinogenesis by indomethacin and butylated hydroxytoluene. Cancer Res. 46:1986;3907-3911.
36. Ip C. Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection. Cancer Lett. 39:1988;239-246.
37. B.S. Reddy, Micronutrients as chemopreventive agents, IARC Sci. Publ. (1996) 221-235.
38. Hohn B. In vitro packaging of lambda and cosmid DNA. Meth. Enzymol. 68:1979;299-309.
39. Maxuitenko Y.Y., Libby A.H., Joyner H.H., Curphey T.J., MacMillan D.L., Kensler T.W., Roebuck B.D. Identification of dithiolethiones with better chemopreventive properties than oltipraz. Carcinogenesis. 19:1998;1609-1615.
40. Sohn O.S., Fiala E.S., Upadhyaya P., Chae Y.H., El-Bayoumy K. Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats. Carcinogenesis. 20:1999;615-621.
41. Otieno M.A., Kensler T.W., Guyton K.Z. Chemoprotective 3H-1,2-dithiole-3-thione induces antioxidant genes in vivo. Free Radic. Biol. Med. 28:2000;944-952.
42. Cerutti P.A. Mechanisms of action of oxidant carcinogens. Cancer Detect. Prev. 14:1989;281-284.
43. Suzuki T. Target organ and time-course in the mutagenicity of five carcinogens in MutaMouse: a summary report of the second collaborative study of the transgenic mouse mutation assay by JEMS/MMS. Mut. Res. 444:1999;259-268.
44. Guess H.A., Hoel D.G. The effect of dose on cancer latency period. J. Environ. Path. Toxicol. 1:1977;279-286.
45. Littlefield N.A., Farmer J.H., Gaylor D.W., Sheldon W.G. Effects of dose and time in a long-term, low-dose carcinogenic study. J. Environ. Path. Toxicol. 3:1980;17-34.
46. Hoel D.G., Kaplan N.L., Anderson M.W. Implication of nonlinear kinetics on risk estimation in carcinogenesis. Science. 219:1983;1032-1037.
47. Hakura A., Tsutsui Y., Sonoda J., Kai J., Imade T., Shimada M., Sugihara Y., Mikami T. Comparison between in vivo mutagenicity and carcinogenicity in multiple organs by benzo[a]pyrene in the lacZ transgenic mouse (MutaMouse). Mut. Res. 398:1998;123-130.